Over-expression of RTKs [37], silencing of PTEN, or mutation of LKB1 [38] are several possible mechanisms that may allow BRAFV600E melanocytes to bypass BRAFV600-mediated suppression of AKT pathway to become full-blown melanoma. This evidence concerns the gene AKT1 and melanoma.